Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia

Published:2016-06 Issue: Volume:249 Page:215-223
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Arai Hidenori,Teramoto Tamio,Daida Hiroyuki,Ikewaki Katsunori,Maeda Yuko,Nakagomi Mariko,Shirakawa Masayoshi,Kakikawa Taro,Numaguchi Hirotaka,Johnson-Levonas Amy O.,Vaidya Sanskruti,Blaustein Robert O.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia;Goldstein;J. Clin. Investig.,1973

2. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation;Watts;J. Clin. Lipidol.,2014

3. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype phenotype relationship, and clinical outcome;Sjouke;Eur. Heart J.,2015

4. National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia;Hopkins;J. Clin. Lipidol.,2011

5. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding;Innerarity;Proc. Natl. Acad. Sci.,1987

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of effect modifiers of genetically predicted CETP reduction;Genetic Epidemiology;2023-01-26

2. Study of effect modifiers of genetically predicted CETP reduction;2021-09-14

3. Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia;Journal of Personalized Medicine;2021-08-31

4. Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis;Progress in Lipid Research;2019-01

5. The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis;Postgraduate Medicine;2017-11-14